PARP inhibitors in epithelial ovarian cancer: what are their potential implications for surgical management?

被引：2
|
作者：
Peters, Inge [1 ,2 ]
Marchetti, Claudia [1 ,2 ]
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Womans & Child Hlth & Publ Hlth Sci, Gynecol Oncol Unit, I-00168 Rome, RM, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
EJSO | 2023年 / 49卷 / 09期
关键词：
Epithelial ovarian cancer; PARP inhibitors; Surgical management; Progression-free survival; Postoperative morbidity; PRIMARY SURGERY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1016/j.ejso.2023.06.025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PARP Inhibitors and the Evolving Landscape of Ovarian Cancer Management: A Review
    Cook, Sarah A.
    Tinker, Anna, V
    BIODRUGS, 2019, 33 (03) : 255 - 273
  • [22] PARP Inhibitors: Strategic Use and Optimal Management in Ovarian Cancer
    Hirschl, Nicholas
    Leveque, Wildnese
    Granitto, Julia
    Sammarco, Valia
    Fontillas, Mervyns
    Penson, Richard T.
    CANCERS, 2024, 16 (05)
  • [23] PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline COMMENT
    不详
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (12) : 739 - +
  • [24] PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations
    Vanacker, Helene
    Harter, Philipp
    Labidi-Galy, Sana Intidhar
    Banerjee, Susana
    Oaknin, Ana
    Lorusso, Domenica
    Ray-Coquard, Isabelle
    CANCER TREATMENT REVIEWS, 2021, 99
  • [25] Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
    Revythis, Antonios
    Limbu, Anu
    Mikropoulos, Christos
    Ghose, Aruni
    Sanchez, Elisabet
    Sheriff, Matin
    Boussios, Stergios
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [26] PARP inhibitors and epithelial ovarian cancer: an approach to targeted chemotherapy and personalised medicine
    Mukhopadhyay, A.
    Curtin, N.
    Plummer, R.
    Edmondson, R. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (04) : 429 - 432
  • [27] PARP Inhibitors in Epithelial Ovarian Cancer: State of Art and Perspectives of Clinical Research
    Gadducci, Angiolo
    Guerrieri, Maria Elena
    ANTICANCER RESEARCH, 2016, 36 (05) : 2055 - 2064
  • [28] PARP INHIBITORS IN OVARIAN CANCER THERAPY
    Pisula, Agata
    Sienicka, Agnieszka
    Dobrowolska-Redo, Agnieszka
    Kacperczyk-Bartnik, Joanna
    Romejko-Wolniewicz, Ewa
    PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (02): : 71 - 74
  • [29] POTENTIAL TARGETED THERAPIES FOR OVARIAN CANCER BEYOND PARP INHIBITORS (REVIEW)
    Sisman, Yagmur
    Hogdall, Dan
    Henrichsen, Tine Schnack
    Hogdall, Claus
    Hogdall, Estrid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A286 - A287
  • [30] PARP Inhibitors in Ovarian Cancer Treatment
    Spriggs, David R.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2197 - 2198
12345